Indian generics grab a strategic foothold in Japan
The recent announcement that Indian generic manufacturer Suven Life Sciences was granted four pharmaceutical patents in China, Mexico and New Zealand, adding to the five patents it holds in Japan, once again shows that Indian generics have steadily…
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.